Our results suggest that an increased ApoB/ApoA1 ratio is associated with worse MetS components, IR, and elevated androgen hormones and liver enzymes and that a higher ApoB/ApoA1 ratio is a promising predictor of MetS and IR in PCOS patients. Here, APOB is linked to metabolic syndrome.